Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

Recruiting now

Conditions studied: Marginal Zone Lymphoma

In brief

This study aims to evaluate real-world treatment modalities and their corresponding effectiveness and safety in Chinese patients with marginal zone lymphoma, while also exploratively analyzing patient characteristics and health-related quality of life.

Key facts

Study ID

NCT06534463

Run by

Ruijin Hospital

People needed

500

Starts

2024-08-02

Expected to finish

2029-09-01

Last updated by the study team

2024-12-03

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be diagnosed as MZL
• Meet the treatment indications for MZL

You may not qualify if…

• Any reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.

Where it is running

• Shanghai Ruijin Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.